Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 98

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 98
---
 risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation:

| ● | Our                                                   
 ability to effectively operate our business segments; |

| ● | Our                                                                                    
 ability to manage our research, development, expansion, growth and operating expenses; |

| ● | Our                                                                              
 ability to evaluate and measure our business, prospects and performance metrics; |

| ● | Our                                                                                           
 ability to compete, directly and indirectly, and succeed in a highly competitive and evolving 
 industry;                                                                                     |

| ● | Our                                                                          
 ability to respond and adapt to changes in technology and customer behavior; |

| ● | Our                                                                                        
 ability to protect our intellectual property and to develop, maintain and enhance a strong 
 brand; and                                                                                 |

| ● | other                                                                                   
 factors (including the risks contained in the section of this prospectus entitled “Risk 
 Factors”) relating to our industry, our operations and results of operations.           |

Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results. USE OF PROCEEDS We are not selling any shares of our common stock in this offering and we will not receive any of the proceeds from the sale of shares of our common stock by the Selling Stockholders. The Selling Stockholders will receive all of the proceeds from any sales of the shares of our common stock offered hereby. However, we will receive aggregate proceeds of up to approximately (i) $1,575,234 from the cash exercise of the January 2025 Common Warrants; (ii) $887,065 from the cash exercise of the February 2025 Warrants; (iii) $97,804 from the cash exercise of the January 2025 Placement Agent Warrants; and (iv